Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin C Thomas

Showing results (141-150 of 171) with videos related to

Pageof 18
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 10, 2014
Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive ratsAmanda K Sampson, Karen L Andrews, Delyth Graham, et al.
Diabetes|April 30, 2009
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetesPer-Henrik Groop, Merlin C Thomas, John L Moran, et al.
Clinical Science (London, England : 1979)|February 1, 2012
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7)Stella Bernardi, Wendy C Burns, Barbara Toffoli, et al.
Hypertension (Dallas, Tex. : 1979)|March 18, 2015
AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathyChristine Koulis, Bryna S M Chow, Maria McKelvey, et al.
Diabetes|September 9, 2010
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mousePhyllis Chew, Derek Y C Yuen, Nada Stefanovic, et al.
Clinical Science (London, England : 1979)|April 15, 2014
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosisChristine Koulis, Peter Kanellakis, Raelene J Pickering, et al.
Circulation Research|March 8, 2003
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changesRiccardo Candido, Josephine M Forbes, Merlin C Thomas, et al.
Kidney International|May 20, 2003
Reduced tubular cation transport in diabetes: prevented by ACE inhibitionMerlin C Thomas, Chris Tikellis, Wendy C Burns, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Kidney International|April 1, 2011
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal functionFrank A Holtkamp, Dick de Zeeuw, Merlin C Thomas, et al.
Pageof 18

Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
Hypertension (Dallas, Tex. : 1979)|September 10, 2014
Origin of the Y chromosome influences intrarenal vascular responsiveness to angiotensin I and angiotensin (1-7) in stroke-prone spontaneously hypertensive ratsAmanda K Sampson, Karen L Andrews, Delyth Graham, et al.
Diabetes|April 30, 2009
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetesPer-Henrik Groop, Merlin C Thomas, John L Moran, et al.
Clinical Science (London, England : 1979)|February 1, 2012
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7)Stella Bernardi, Wendy C Burns, Barbara Toffoli, et al.
Hypertension (Dallas, Tex. : 1979)|March 18, 2015
AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathyChristine Koulis, Bryna S M Chow, Maria McKelvey, et al.
Diabetes|September 9, 2010
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mousePhyllis Chew, Derek Y C Yuen, Nada Stefanovic, et al.
Clinical Science (London, England : 1979)|April 15, 2014
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosisChristine Koulis, Peter Kanellakis, Raelene J Pickering, et al.
Circulation Research|March 8, 2003
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changesRiccardo Candido, Josephine M Forbes, Merlin C Thomas, et al.
Kidney International|May 20, 2003
Reduced tubular cation transport in diabetes: prevented by ACE inhibitionMerlin C Thomas, Chris Tikellis, Wendy C Burns, et al.
Journal of Molecular Endocrinology|August 10, 2005
High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunctionSuwattanee Kooptiwut, Melkam Kebede, Sakeneh Zraika, et al.
Kidney International|April 1, 2011
An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal functionFrank A Holtkamp, Dick de Zeeuw, Merlin C Thomas, et al.
Pageof 18